These results confirm and define novel proteogenomic alterations in uterine leiomyoma tissues collected from HLRCC patients and underscore conserved molecular alterations correlating with inactivation of the FH tumor suppressor gene. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.